US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ホーム
投資
株式
アメリカ
USOTC
Sakata Seed Corporation (PK) (SKSDF) 銘柄情報

Sakata Seed Corporation (PK) (SKSDF)

25.25

0.00

(0.00%)

終了 7月12日 5:00AM

Sakata Seed Corporation (PK) (SKSDF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

25.25

( - )

買値

23.66

売値

29.66

出来高

-

平均取引量 (3 か月)

US$ 181,693

財務取引量

-

0.00 日の範囲 0.00

22.65 52 週間の範囲 25.25

時価総額

企業価値

150.855B

前日終値

25.25

始値

-

時刻

最終取引時間

VWAP

-

歳入

99.18B

純利益

10.59B

発行済株式数

42,259,696

浮動株比率 (%)

78.19%

機関投資家保有比率 (%)

28.52%

配当利回り

80

PER

16.91

株価売上高倍率 (PSR)

1.77

1 株当たり利益 (EPS)

246.24

ベータ

-0.05

Sakata Seed Corporation produces and sells vegetable and flower seeds, bulbs, plants, and agricultural and horticultural supplies in Japan, the Americas, Europe, the Middle East, the rest of Asia, and internationally. It also engages in the publication of gardening literature; plant breeding; resear... Sakata Seed Corporation produces and sells vegetable and flower seeds, bulbs, plants, and agricultural and horticultural supplies in Japan, the Americas, Europe, the Middle East, the rest of Asia, and internationally. It also engages in the publication of gardening literature; plant breeding; research and development, and technical consultation of consigned seed production; and designing, management, and contract construction of landscaping, greenhouse, and horticultural facilities. The company was formerly known as T. Sakata & Company and changed its name to Sakata Seed Corporation in January 1986. Sakata Seed Corporation was founded in 1913 and is headquartered in Yokohama, Japan. 詳細を表示

セクター

-

業界

-

ウェブサイト

corporate.sakataseed.co.jp

本社

Yokohama, Japan

設立

2026

Sakata Seed Corporation (PK) is listed in the sector of the その他OTC with ticker SKSDF. The last closing price for Sakata Seed (PK) was US$25.25. Over the last year, Sakata Seed (PK) shares have traded in a share price range of US$ 22.65 to US$ 25.25.

Sakata Seed (PK) currently has 42,259,696 shares in issue. The market capitalisation of Sakata Seed (PK) is US$1.07 billion. Sakata Seed (PK) has a price to earnings ratio (PE ratio) of 16.91.

Deleted Symbol

Thu, Mar 14, 2013 12:00 - Sakata Seed Corp. (SKSDF: Grey Market) - Deleted Symbol - As of Thu, Mar 14, 2013, SKSDF is no longer a valid symbol...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	25.25	25.25	25.25	0	0	CS
26	0	0	25.25	25.25	25.25	0	0	CS
52	2.6	11.4790286976	22.65	25.25	22.65	125	24.834	CS
156	9	55.3846153846	16.25	25.25	16.25	107	24.48766667	CS
260	9	55.3846153846	16.25	25.25	16.25	88	24.48766667	CS

SKSDF - Frequently Asked Questions (FAQ)

What is the current Sakata Seed Corporation (PK) share price?

The current share price of Sakata Seed Corporation (PK) is US$ 25.25

How many Sakata Seed Corporation (PK) shares are in issue?

Sakata Seed Corporation (PK) has 42,259,696 shares in issue

What is the market cap of Sakata Seed Corporation (PK)?

The market capitalisation of Sakata Seed Corporation (PK) is USD 1.07B

What is the 1 year trading range for Sakata Seed Corporation (PK) share price?

Sakata Seed Corporation (PK) has traded in the range of US$ 22.65 to US$ 25.25 during the past year

What is the PE ratio of Sakata Seed Corporation (PK)?

The price to earnings ratio of Sakata Seed Corporation (PK) is 16.91

What is the cash to sales ratio of Sakata Seed Corporation (PK)?

The cash to sales ratio of Sakata Seed Corporation (PK) is 1.77

What is the registered address of Sakata Seed Corporation (PK)?

The registered address for Sakata Seed Corporation (PK) is 2-7-1 Nakamachidai, Yokohama, Kanagawa, 224-0041

What is the Sakata Seed Corporation (PK) website address?

The website address for Sakata Seed Corporation (PK) is corporate.sakataseed.co.jp

sharkey1

sharkey1 5分前

And so does Kirko.

wadegarret

wadegarret 5分前

Best year 2009 up 580%- This year up 290% so far

That is, in my real portfolio. Sometimes Wadegarret portfolio performs better, and sometime worse, as I do more trading in my real portfolio. Gernerally speaking I play the same stocks, but sometimes I do a lot more trading in my

Nightdaytrader

Nightdaytrader 6分前

They better do it before October elections because if Dems win, nothing will happen and then in January, 2027, I think Maxine Waters will take over House Banking Committee that oversees FDIC.

Baxers

If they had disclosed then the other side would have had a runaway field day on the information and the stock price would be even further in bits and raising capital would be even more difficult that it already is. Entirely unsurprised that (if my idea is correct) they didn't disclose. Caught betwee

Goats'nCrows

Goats'nCrows 8分前

LC, I have been paying attention, and I have been reading your stances. I mean no offense or attack but I can no more believe that you are spending Saturday to selflessly convince shareholders to save themselves/the company than I can believe the "Cofer is under your bed" crowd.

Ar

learningcurve2020

learningcurve2020 10分前

So what’s Advent doing with 85 employees and about $30M in revenues back in 2024? Plus they have the business and Cognate / River to hold their hand. My belief is they already pivoted as you can see by Advent’s website.

Nemesis18

Nemesis18 15分前

I didn't feel that I needed to answer, but
if the MHRA or FDA issues a definitive rejection or demands a completely new Phase III trial, due to the trial's controversial external-control design, NWBO's valuation will face an existential threat.
Without DCVax-L approval, they would b

kenjiroo

kenjiroo 15分前

I hope I can still spin my head at old age !! Cant wait forever 😜

learningcurve2020

learningcurve2020 16分前

If you were at all paying attention my stance has always been to get off your sheepish butts before it’s too late to 1) force new management 2) claw back Advent 3) get the CDMO up and running! Somehow 2 was achieved but sneakily without the revenues, sadly.

Steady_T

Steady_T 17分前

Wouldn't ADVENT be a wholly owned subsidiary?

CryptoRain

CryptoRain 18分前

Yes it does but those holding through the Jan 5 ex date and then sold will most likely get it too. This company is doing things right

kspar1

kspar1 18分前

https://www.patreon.com/posts/163510848

Impressions on The CHMP Blarcamesine Rejection Justification"

Upbeat re-visit of the CHMP conclusion by Bio_Oko. Basically, he observes that Anavex was trying to get those folks to see the goodness in the numbers, hoping they'd i

Lime Time

Lime Time 18分前

Yeah forgot about this one. Bigtime scam in the past. They used to advertise on iHub. Really good share structure. Will check it out. They put it in the time capsule in 2023. Someone gotta open it up some day

boston745

boston745 19分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

boston745

boston745 19分前

Another example where current management, but not current board, kept Sintx undervalued was back in February of 2025. This attempt to keep Sintx undervalued likely had multiple reasons behind it but that list definitely includes keeping Sintx undervalued for the offering in February and likely again

Jetmek_03052

Jetmek_03052 20分前

As usual, you are wrong.

I never said I was an "expert" on DBMM's financial reports. I said I had forecast DBMM's revenues pretty accurately. And my past posts about them have been proven to be just that.

Where did I say I was an "expert"? Sounds like your opinion a

Steady_T

Steady_T 20分前

$.17 is proof that the drug has not been approved in 923 days.

The jury i.e. MHRA is still out on whether the drug works or not.

Any other conclusion is based on wishful thinking.

Bizreader

Bizreader 20分前

Yep and let's see what happens going forward giving the current state of affairs. Maybe a pendulum or whiplash experience may be next up giving patterns of history.

larrybaz

larrybaz 21分前

Thanks for all the hard work, SSKILLZ. Should be an interesting contest. I'll be interested to see how the indices fare. We will find out if our collective stock-picking ability paints us as contenders or pretenders!

02opida

02opida 21分前

Recent Trades -
Time ET Ex Price Change Volume
15:36:59 Q 0.0071 0.0008 200,000
15:30:40 Q 0.0071 0.0008 13,579
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
14:49:32 Q 0.00704 0.00074 25,000
14:49:32 Q 0.007 0.0007 25,000
1

randomwalk007

randomwalk007 22分前

The reason it’s taken so long is BIOAQ had to wait until CERN was shut down to close off the parallel universe and enable the completion of the merger. Duh!

radly

Is this going lower or is it time to buy?

02opida

02opida 23分前

70 out here at the foot of the mountain

Goats'nCrows

Goats'nCrows 23分前

Company is broke.

And I think I can fairly assume you would be willing to add that we longs are about to languish in more silence...waiting on certain death.

So why all the effort if we're really about to get our comeuppance as a result of the ill behavior you attrib

Sakata Seed (PK)

Cooper Companies

Jpmorgan Chase Financial...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。